Champions Oncology, Inc. (CSBR)

Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 2, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	84	98	66	67	104	144
Market Cap Growth	-44.51%	48.65%	-1.17%	-35.77%	-27.72%	56.56%
Enterprise Value	81	101	69	64	105	143
Last Close Price	6.07	7.15	4.85	4.92	7.68	10.73
PE Ratio	34.78	20.85	-	-	189.51	396.90
Forward PE	121.40	119.17	-	-	42.95	77.31
PS Ratio	1.44	1.72	1.32	1.24	2.12	3.50
PB Ratio	20.21	25.98	-34.65	14.39	11.42	19.34
P/TBV Ratio	21.98	28.51	-	15.51	11.85	20.26
P/FCF Ratio	14.95	14.01	-	60.64	25.25	-
P/OCF Ratio	13.54	13.27	-	16.80	15.99	-
PEG Ratio	-	-	-	-	6.09	6.09
EV/Sales Ratio	1.39	1.78	1.38	1.19	2.13	3.48
EV/EBITDA Ratio	20.45	15.65	-	-	46.90	92.05
EV/EBIT Ratio	32.96	20.94	-	-	172.63	389.82
EV/FCF Ratio	14.39	14.51	-	58.12	25.48	-
Debt / Equity Ratio	1.28	1.68	-3.90	1.86	1.04	1.29
Debt / EBITDA Ratio	0.94	0.76	-	-	2.29	3.37
Debt / FCF Ratio	0.96	0.90	-	7.82	2.30	-
Net Debt / Equity Ratio	-0.73	-0.92	-2.53	-0.33	0.05	0.66
Net Debt / EBITDA Ratio	-0.78	-0.53	-0.95	0.54	0.21	3.17
Net Debt / FCF Ratio	-0.55	-0.49	-0.69	-1.38	0.11	-0.99
Asset Turnover	2.11	1.95	1.66	1.55	1.56	1.70
Quick Ratio	0.91	0.88	0.56	0.83	1.06	1.04
Current Ratio	0.96	0.94	0.63	0.90	1.13	1.13
Return on Equity (ROE)	98.94%	503.05%	-532.46%	-77.70%	6.63%	5.78%
Return on Assets (ROA)	5.56%	10.36%	-14.31%	-7.98%	1.21%	0.95%
Return on Invested Capital (ROIC)	1811.03%	300.90%	-229.71%	-70.22%	5.21%	4.70%
Return on Capital Employed (ROCE)	30.70%	57.10%	-150.80%	-35.40%	3.40%	2.20%
Earnings Yield	2.96%	4.80%	-11.04%	-8.00%	0.53%	0.25%
FCF Yield	6.69%	7.14%	-10.58%	1.65%	3.96%	-3.45%
Buyback Yield / Dilution	-4.06%	-5.31%	-0.04%	4.37%	2.84%	-23.05%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q